ABSTRACT
Objective.
To establish whether there was any difference in disease stage in patients with screening-detected colorectal cancer (CRC) in a Caribbean country.
Methods.
The mode of presentation (elective vs. emergent), method of diagnosis (screening vs. symptomatic), and disease stage were retrospectively compared in all consecutive patients who had resections for CRC over a five-year period. Early CRC was defined as disease that could be completely resected with no involvement of adjacent organs, lymph nodes, or distant sites. Locally advanced CRC was disease that involved contiguous organs without distant metastases that was still amenable to curative resection.
Results.
There were 97 patients at a mean age of 64.9 ± 12.2 years treated for CRC, and only 21 (21.6%) had their diagnoses made through screening. Significantly more screening-detected lesions were early-stage CRCs (21.7% vs. 9.3%; p < 0.001). At the time of diagnosis, patients who did not have screening-detected lesions had a greater proportion of locally advanced (42.3% vs. 0) and metastatic (26.8% vs. 0) CRC. Those who did not have screening-detected lesions had a greater incidence of emergency presentations at diagnosis (26.8% vs. 0).
Conclusions.
The incidence of screening-detected CRC in this Caribbean nation was low. Consequently, most patients presented with locally advanced or metastatic CRC, for which there is less opportunity to achieve a cure. Significantly more screening-detected lesions were early-stage CRCs. It is time for policymakers to develop a national CRC screening program.
Keywords
Colorectal neoplasms; Barbados; Caribbean region
RESUMEN
Objetivo.
Determinar las diferencias en el estadio de la enfermedad en pacientes con cáncer colorrectal diagnosticado mediante un programa de detección sistemática en un país del Caribe.
Métodos.
Se realizó una comparación en retrospectiva de la modalidad de presentación (programada o de urgencia), el método de diagnóstico (por detección sistemática o por síntomas) y el estadio de la enfermedad en todos los pacientes consecutivos con resecciones por cáncer colorrectal en un período de cinco años. Se definió el cáncer colorrectal en fase inicial o incipiente como una enfermedad que puede extirparse completamente sin la afectación de los órganos adyacentes, los ganglios linfáticos o focos distantes. Se consideró el cáncer colorrectal localmente avanzado como una enfermedad que afecta a los órganos contiguos sin metástasis a distancia y aún susceptible de resección curativa.
Resultados.
Hubo 97 pacientes de una media de edad de 64,9 ± 12,2 años en tratamiento por cáncer colorrectal y únicamente 21 (21,6%) habían recibido un diagnóstico mediante un programa de detección sistemática. Un número significativamente mayor de los diagnósticos dados por detección sistemática se trató de cáncer colorrectal de fase inicial (21,7 % frente a 9,3 %; p < 0,001). En el momento del diagnóstico, se registró una mayor proporción de cáncer colorrectal localmente avanzado (42,3 % frente a 0) y metastásico (26,8 % frente a 0) en los pacientes sin lesiones diagnosticadas en un programa de detección sistemática. Los pacientes cuyas lesiones no fueron diagnosticadas mediante la detección sistemática registraron una mayor incidencia de presentaciones de urgencia en el momento del diagnóstico (26,8 % frente a 0).
Conclusiones.
La incidencia de cáncer colorrectal diagnosticado mediante detección sistemática en este país del Caribe fue baja. En consecuencia, la mayoría de los pacientes presentó cáncer colorrectal localmente avanzado o metastásico, cuya oportunidad de cura es menor. Un número significativamente mayor de lesiones diagnosticadas mediante detección sistemática se trató de cáncer colorrectal de fase inicial. Ha llegado el momento de que las personas responsables de las políticas elaboren un programa nacional de detección sistemática de cáncer colorrectal.
Palabras clave
Neoplasias colorrectales; Barbados; región del Caribe
RESUMO
Objetivo.
Determinar se houve diferença no estágio da doença detectada no exame de prevenção de câncer colorretal em um país do Caribe.
Métodos.
Fatores como tipo de apresentação (eletiva vs. de emergência), método de diagnóstico (prevenção vs. detecção sintomática) e estágio da doença foram comparados retrospectivamente em todos os pacientes consecutivos submetidos a cirurgia de ressecção de câncer colorretal em um período de cinco anos. Definiu-se doença em estágio inicial como o tumor passível de ressecção total sem o envolvimento de órgãos adjacentes, gânglios linfáticos ou sítios a distância, e doença localmente avançada como o tumor envolvendo órgãos contíguos, sem metástase a distância, mas passível de resseção curativa.
Resultados.
Noventa e sete pacientes com média de idade de 64,9 ± 12,2 anos foram tratados devido ao câncer colorretal e apenas 21 (21,6%) tiveram a doença diagnosticada no exame de prevenção. Um percentual significativamente maior de lesões detectadas no exame de prevenção estava em estágio inicial (21,7% vs. 9,3%; p < 0.001). No momento do diagnóstico, os pacientes cujas lesões de câncer colorretal não foram detectadas com o exame de prevenção apresentaram um maior percentual de doença localmente avançada (42,3% vs. 0) ou metastática (26,8% vs. 0). Houve também, entre esses pacientes, uma maior incidência de apresentação em caráter de emergência (26,8% vs. 0).
Conclusões.
Observou-se uma baixa incidência de câncer colorretal na população deste país do Caribe. Porém, a maioria dos pacientes apresentou doença localmente avançada ou metastática no diagnóstico – uma situação associada a uma menor chance de cura. O percentual de lesões detectadas em estágio inicial com o exame de prevenção foi significativamente maior. As autoridades de saúde devem aproveitar a oportunidade e instituir um programa nacional de prevenção do câncer colorretal.
Palavras-chave
Neoplasias colorretais; Barbados; região do Caribe
Barbados is a Small Island Developing State in the Eastern Caribbean with a population of 287 371 inhabitants (11. International Agency for Research on Cancer; World Health Organization. Globocan 2020: Barbados [Factsheet]. Lyon: IARC; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/52-barbados-fact-sheets.pdf
https://gco.iarc.fr/today/data/factsheet... ). Barbados has one of the highest age-standardized colorectal cancer (CRC) incidence rates in the world (22. World Cancer Research Fund; American Institute for Cancer Research [Internet]. London: WCRF International; c2019 [cited 2019 May 1]. Colorectal cancer statistics. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics
https://www.wcrf.org/dietandcancer/cance... ). Recent Globocan data published by the International Agency for Research on Cancer/World Health Organization identified CRC as the second commonest cause of cancer-related mortality on the island (11. International Agency for Research on Cancer; World Health Organization. Globocan 2020: Barbados [Factsheet]. Lyon: IARC; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/52-barbados-fact-sheets.pdf
https://gco.iarc.fr/today/data/factsheet... ).
The principle of secondary prevention is to identify a disease before symptoms appear, when patients can be treated with curative intent. With such a high burden of CRC in Barbados (11. International Agency for Research on Cancer; World Health Organization. Globocan 2020: Barbados [Factsheet]. Lyon: IARC; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/52-barbados-fact-sheets.pdf
https://gco.iarc.fr/today/data/factsheet... , 22. World Cancer Research Fund; American Institute for Cancer Research [Internet]. London: WCRF International; c2019 [cited 2019 May 1]. Colorectal cancer statistics. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics
https://www.wcrf.org/dietandcancer/cance... ), secondary prevention should be a priority for this nation. Nevertheless, up to the year 2021, there were no national screening programs in Barbados.
We carried out this study in an attempt to increase awareness of CRC screening. The aim was to determine the proportion of patients with CRC diagnoses who were detected through screening and to determine whether there was any difference in disease stage at diagnosis.
MATERIALS AND METHODS
The Government of Barbados provides free health care to all legal residents through a government-administered taxation scheme. In this subsidized health care system, there is no national screening program for CRC. Persons are generally sent for fecal occult blood testing and/or colonoscopy when they develop gastrointestinal symptoms and occasionally when heath care providers recommend ad hoc (opportunistic) screening for high-risk persons. Patients diagnosed with CRC are referred to the Queen Elizabeth Hospital, the island’s sole government-subsidized tertiary referral center, for colectomy and adjuvant systemic therapy.
Ethical approval was secured from the institutional review board to retrospectively audit records of patients who had resections for CRC between 1 January 2014 and 1 January 2019. The patient records were retrieved and the following data were extracted: patient demographics, mode of presentation (elective vs. emergent), method of diagnosis (screening vs. symptomatic), and American Joint Committee on Cancer (AJCC) stage.
Early CRC was defined as disease that could be completely resected with no involvement of adjacent organs, lymph nodes, or distant sites (AJCC stages 0, I, and IIa). Locally advanced CRC was defined as disease that involved contiguous organs and without distant metastases, that was still amenable to curative resection (AJCC stage IIb, IIc, and III). Metastatic disease indicated the presence of distant spread.
Disease stage was compared based on mode of presentation and method of diagnosis. Descriptive statistical analysis was generated using SPSS version 21.0. A descriptive analysis for the data set was performed using the Chi square test of independence to investigate correlations. A p-value of 0.05 was considered significant.
RESULTS
There were 97 patients with a mean age of 64.9 years (standard deviation [SD] 12.2) treated for CRC over the study period. There was a higher proportion of males (1.3:1), with 54 males at a mean age of 64.5 years (median 64; mode 64; SD 11.3) and 43 females at a mean age of 65.4 years (median 63; mode 58; SD 13.5).
There were 21 (21.6%) patients who had diagnoses made through screening and 76 (78.4%) who had investigations after developing symptoms. Significantly more screening-detected lesions were early-stage CRCs (21.7% vs. 9.3%; p < 0.001). Table 1 compares the AJCC stages in both patient groups.
We evaluated all patients according to their mode of presentation. There were 26 (26.8%) patients who had CRC diagnoses made after presenting as an emergency with malignant bowel obstruction (19), perforation (55. Buskermolen M, Cenin DR, Helsingen LM, Guyatt G, Vandvik PO, Haug U et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. BMJ. 2019;367:I5383.), or bleeding (22. World Cancer Research Fund; American Institute for Cancer Research [Internet]. London: WCRF International; c2019 [cited 2019 May 1]. Colorectal cancer statistics. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics
https://www.wcrf.org/dietandcancer/cance... ). At the time of diagnosis, patients who did not have screening-detected lesions had a greater proportion of locally advanced (42.3% vs. 0) and metastatic (26.8% vs. 0) CRC. In the 71 patients who had diagnoses made on an elective basis, 25 (35.2%) still had early CRC at the time of presentation. Table 2 compares AJCC stage at the time of diagnosis. We did not find any statistically significant difference in disease stage depending on mode of presentation.
DISCUSSION
One of the main principles behind CRC treatment is secondary prevention: to address the disease when there is still an opportunity to achieve complete resection and potential cure. Therefore, most authorities recommend screening for CRC (33. Benson AB, Venook AP, Al Hawary MM, Cederquist L, Chen Y-J; National Comprehensive Cancer Network, et al. NCCN Harmonized Guidelines for the Caribbean: Colorectal Cancer. Version 2.2018. Plymouth Meeting, PA: NCCN; 2018. Available from: https://www.nccn.org/professionals/physician_gls/pdf/colon_harmonized-caribbean.pdf
https://www.nccn.org/professionals/physi... –55. Buskermolen M, Cenin DR, Helsingen LM, Guyatt G, Vandvik PO, Haug U et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. BMJ. 2019;367:I5383.).
Although CRC screening is recommended, most Caribbean countries, including Barbados, have not instituted comprehensive CRC screening programs. Most practice opportunistic screening, where selected individuals are subjected to ad hoc screening depending on recommendations from their physicians. This is largely due to a lack of prioritization by policymakers.
Every year in Barbados, 14.8 individuals per 100 000 population are diagnosed with CRC (11. International Agency for Research on Cancer; World Health Organization. Globocan 2020: Barbados [Factsheet]. Lyon: IARC; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/52-barbados-fact-sheets.pdf
https://gco.iarc.fr/today/data/factsheet... ). In fact, the World Cancer Research Fund/American Institute for Cancer Research ranked Barbados as having the highest incidence of CRC across the Caribbean (22. World Cancer Research Fund; American Institute for Cancer Research [Internet]. London: WCRF International; c2019 [cited 2019 May 1]. Colorectal cancer statistics. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics
https://www.wcrf.org/dietandcancer/cance... ) and the eighth highest age-standardized rate of CRC in the world (22. World Cancer Research Fund; American Institute for Cancer Research [Internet]. London: WCRF International; c2019 [cited 2019 May 1]. Colorectal cancer statistics. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics
https://www.wcrf.org/dietandcancer/cance... ). It would stand to reason that a national screening program should be prioritized in this high-risk population. However, we have shown that a small proportion of persons with CRC have their diagnoses made through screening. More importantly, screening allowed significantly more patients to have diagnoses made at an early disease stage (21.7% vs. 9.3%). It stands to reason, therefore, that a properly organized national screening program would detect a larger proportion of patients with early CRC. By extension, a larger number of patients would be candidates for R0 resection and potential cure.
Apart from a greater potential for curative R0 resection, patients with early CRC are more likely to have their colectomy performed through the laparoscopic approach compared to those with locally advanced disease (66. Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis. 2011;13(2):138–43.). Well-designed studies have proved the advantages of the laparoscopic approach to colectomy in international (77. Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008(2): CD003432.) and Caribbean literature (88. Leake PA, Pitzul K, Roberts PO, Plummer JM. Comparative analysis of open and laparoscopic colectomy for malignancy in a developing country. World J Gastrointest Surg. 2013;5(11):294–9.).
In this study population, 69.1% of persons already had locally advanced or metastatic CRC at the time of diagnosis. Existing data show that there are worse clinical outcomes in persons with advanced stages of CRC (66. Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis. 2011;13(2):138–43., 77. Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008(2): CD003432.). The five-year survival rate after treatment falls from approximately 70% for patients with early CRC to 30% for those with locally advanced disease (66. Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis. 2011;13(2):138–43.) and only 5%–10% for those with metastatic disease (99. Masi G, Vasile E, Loupakis F, Cupini S, Fornaro L, Baldi G, et al. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst. 2011;103(1):21–30.). Also, patients undergoing surgery for locally advanced CRC have greater postoperative morbidity and mortality (1010. Ascanelli S, Navarra G, Tonini G, Feo C, Zerbinati A, Pozza E et al. Early and late outcome after surgery for colorectal cancer elective versus emergency surgery. Tumori. 2003;89(1):36–41.) than those with early CRC. This provides further impetus to implement CRC in this nation.
Globally, the treatment of patients with CRC is a significant economic burden, with estimates from the United States of America in the year 2000 in the range of US$ 5–6 billion per annum (1111. Redaelli A, Cranor CW, Okano GJ, Reese PR. Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer. Pharmacoeconomics. 2003;21(17):1213–38.). Of this, 80% of the expenditure was related to inpatient costs (1111. Redaelli A, Cranor CW, Okano GJ, Reese PR. Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer. Pharmacoeconomics. 2003;21(17):1213–38.), often as a result of complicated CRC. While there is little economic data from the English-speaking Caribbean, Torres et al. (1212. Torres UDS, Almeida TEP, Netinho JG. Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008. Rev Panam Salud Publica. 2010;28(4):244–8.) reported a significant rise in CRC-related expenditure in Brazil, from US$ 1.65 million in 1996 to US$ 33.5 million in 2008, mirroring the rise in emergency admissions. We expect a similar trend in the Caribbean, as we have demonstrated that 27% of patients have their diagnosis made on emergency presentation to hospital in Barbados. Assuming that screening programs would reduce the number of emergency presentations, it stands to reason that this would also bring a reduction in expenditure related to treatment of these emergencies.
In our study, 26.8% of patients presented as emergent cases of CRC with complications. There are existing data to show that patients have a worse clinical outcome and lower five-year survival when they develop malignant bowel obstruction and perforation (1313. Chen TM, Huang YT, Wang GC. Outcome of colon cancer initially presenting as colon perforation and obstruction. World J Surg Oncol. 2017;15(1):164.). Although the proportion of early CRC in our study was lower in patients who presented as emergent cases (19.2% vs. 35.2%), we did not find a statistical association. Nevertheless, we suggest that it is still clinically important to aim for a reduction in emergency presentations, because these patients have less opportunity for laparoscopic colectomies (66. Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis. 2011;13(2):138–43., 1414. Bayar B, Yılmaz KB, Akıncı M, Şahin A, Kulaçoğlu H. An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients. Ulus Cerrahi Derg. 2016;32(1):11–17.), fewer curative R0 resections (1414. Bayar B, Yılmaz KB, Akıncı M, Şahin A, Kulaçoğlu H. An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients. Ulus Cerrahi Derg. 2016;32(1):11–17.), greater post-operative morbidity rates (1010. Ascanelli S, Navarra G, Tonini G, Feo C, Zerbinati A, Pozza E et al. Early and late outcome after surgery for colorectal cancer elective versus emergency surgery. Tumori. 2003;89(1):36–41., 1414. Bayar B, Yılmaz KB, Akıncı M, Şahin A, Kulaçoğlu H. An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients. Ulus Cerrahi Derg. 2016;32(1):11–17.), and higher perioperative mortality (1010. Ascanelli S, Navarra G, Tonini G, Feo C, Zerbinati A, Pozza E et al. Early and late outcome after surgery for colorectal cancer elective versus emergency surgery. Tumori. 2003;89(1):36–41.) compared with patients who have their diagnoses made on an elective basis.
These are important data that could shape public health policies and guide screening protocols in Barbados. Ultimately, these tailored policies would increase early diagnosis and improve therapeutic outcomes in this population.
Limitations
One limitation of this study was that the study methodology only allowed collection of data from patients undergoing surgery for CRC. Data for patients with early CRC treated endoscopically and those with stage IV CRC who were not amenable to surgical treatment would not be included in the data collection.
Conclusion
The incidence of screening-detected CRC in this Caribbean nation was low. Consequently, most patients present with locally advanced (42.3%) or metastatic (26.8%) CRC, for which there is less opportunity to achieve a cure. The evidence presented here supports screening by showing that significantly more screening-detected lesions were early-stage CRCs (21.7% vs. 9.3%; p < 0.001). It is time for policymakers to develop and institute a national screening program for CRC.
Disclaimer.
Authors hold sole responsibility for the views expressed in the manuscript, which may not necessarily reflect the opinion or policy of the Revista Panamericana de Salud Pública/Pan American Journal of Public Health and/or those of the Pan American Health Organization.
- Author contributions.SG, SOC, and SM conceived the original idea and planned the data collection. SG, SOC, GP, and SR collected and analyzed the data. SG, EP, GP, and SOC performed the analysis and interpreted the findings. SG and SOC wrote the paper. All authors reviewed and approved the final version.
- Conflict of interest.None declared.
REFERENCES
- 1.International Agency for Research on Cancer; World Health Organization. Globocan 2020: Barbados [Factsheet]. Lyon: IARC; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/52-barbados-fact-sheets.pdf
» https://gco.iarc.fr/today/data/factsheets/populations/52-barbados-fact-sheets.pdf - 2.World Cancer Research Fund; American Institute for Cancer Research [Internet]. London: WCRF International; c2019 [cited 2019 May 1]. Colorectal cancer statistics. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics
» https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics - 3.Benson AB, Venook AP, Al Hawary MM, Cederquist L, Chen Y-J; National Comprehensive Cancer Network, et al. NCCN Harmonized Guidelines for the Caribbean: Colorectal Cancer. Version 2.2018. Plymouth Meeting, PA: NCCN; 2018. Available from: https://www.nccn.org/professionals/physician_gls/pdf/colon_harmonized-caribbean.pdf
» https://www.nccn.org/professionals/physician_gls/pdf/colon_harmonized-caribbean.pdf - 4.Meester RGS, Peterse EFP, Knudsen AB, de Weerdt AC, Chen JC, Lietz AP, et al. Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124(14):2974–85.
- 5.Buskermolen M, Cenin DR, Helsingen LM, Guyatt G, Vandvik PO, Haug U et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. BMJ. 2019;367:I5383.
- 6.Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis. 2011;13(2):138–43.
- 7.Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008(2): CD003432.
- 8.Leake PA, Pitzul K, Roberts PO, Plummer JM. Comparative analysis of open and laparoscopic colectomy for malignancy in a developing country. World J Gastrointest Surg. 2013;5(11):294–9.
- 9.Masi G, Vasile E, Loupakis F, Cupini S, Fornaro L, Baldi G, et al. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst. 2011;103(1):21–30.
- 10.Ascanelli S, Navarra G, Tonini G, Feo C, Zerbinati A, Pozza E et al. Early and late outcome after surgery for colorectal cancer elective versus emergency surgery. Tumori. 2003;89(1):36–41.
- 11.Redaelli A, Cranor CW, Okano GJ, Reese PR. Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer. Pharmacoeconomics. 2003;21(17):1213–38.
- 12.Torres UDS, Almeida TEP, Netinho JG. Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008. Rev Panam Salud Publica. 2010;28(4):244–8.
- 13.Chen TM, Huang YT, Wang GC. Outcome of colon cancer initially presenting as colon perforation and obstruction. World J Surg Oncol. 2017;15(1):164.
- 14.Bayar B, Yılmaz KB, Akıncı M, Şahin A, Kulaçoğlu H. An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients. Ulus Cerrahi Derg. 2016;32(1):11–17.
Publication Dates
- Publication in this collection
14 Apr 2023 - Date of issue
2022
History
- Received
22 May 2021 - Accepted
24 Nov 2021